JP2012065652A5 - - Google Patents

Download PDF

Info

Publication number
JP2012065652A5
JP2012065652A5 JP2011214253A JP2011214253A JP2012065652A5 JP 2012065652 A5 JP2012065652 A5 JP 2012065652A5 JP 2011214253 A JP2011214253 A JP 2011214253A JP 2011214253 A JP2011214253 A JP 2011214253A JP 2012065652 A5 JP2012065652 A5 JP 2012065652A5
Authority
JP
Japan
Prior art keywords
cells
sendai virus
vector
cell
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011214253A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012065652A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2011214253A priority Critical patent/JP2012065652A/ja
Priority claimed from JP2011214253A external-priority patent/JP2012065652A/ja
Publication of JP2012065652A publication Critical patent/JP2012065652A/ja
Publication of JP2012065652A5 publication Critical patent/JP2012065652A5/ja
Pending legal-status Critical Current

Links

JP2011214253A 2003-11-04 2011-09-29 遺伝子導入された樹状細胞の製造方法 Pending JP2012065652A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011214253A JP2012065652A (ja) 2003-11-04 2011-09-29 遺伝子導入された樹状細胞の製造方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2003374808 2003-11-04
JP2003374808 2003-11-04
JP2004187028 2004-06-24
JP2004187028 2004-06-24
JP2011214253A JP2012065652A (ja) 2003-11-04 2011-09-29 遺伝子導入された樹状細胞の製造方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2005515163A Division JPWO2005042737A1 (ja) 2003-11-04 2004-10-29 遺伝子導入された樹状細胞の製造方法

Publications (2)

Publication Number Publication Date
JP2012065652A JP2012065652A (ja) 2012-04-05
JP2012065652A5 true JP2012065652A5 (enExample) 2012-12-20

Family

ID=34554806

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2005515163A Withdrawn JPWO2005042737A1 (ja) 2003-11-04 2004-10-29 遺伝子導入された樹状細胞の製造方法
JP2011214253A Pending JP2012065652A (ja) 2003-11-04 2011-09-29 遺伝子導入された樹状細胞の製造方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2005515163A Withdrawn JPWO2005042737A1 (ja) 2003-11-04 2004-10-29 遺伝子導入された樹状細胞の製造方法

Country Status (8)

Country Link
US (1) US20070269414A1 (enExample)
EP (1) EP1690937B1 (enExample)
JP (2) JPWO2005042737A1 (enExample)
KR (1) KR101279748B1 (enExample)
CN (1) CN1902312B (enExample)
AU (1) AU2004286144A1 (enExample)
CA (1) CA2544786A1 (enExample)
WO (1) WO2005042737A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7335296A (en) 1995-11-01 1997-05-22 Dnavec Research Inc. Recombinant sendai virus
US20030166252A1 (en) * 1999-05-18 2003-09-04 Kaio Kitazato Paramyxovirus-derived RNP
US20020002143A1 (en) * 2000-03-30 2002-01-03 Munehide Kano AIDS virus vaccines using sendai virus vector
JP2002142770A (ja) * 2000-11-08 2002-05-21 Dnavec Research Inc 循環系への遺伝子送達用パラミクソウイルスベクター
AU2003275581A1 (en) * 2002-10-24 2004-05-13 Dnavec Research Inc. Method of transferring gene into t cells
EP1642966B1 (en) * 2003-06-30 2010-03-03 Dnavec Research Inc. Minus strand rna viral vectors carrying a gene with altered hypermutable regions
AU2004286144A1 (en) * 2003-11-04 2005-05-12 Dnavec Research Inc. Method for producing gene transferred dendritic cells
AU2005205441A1 (en) * 2004-01-13 2005-07-28 Dnavec Research Inc. Gene therapy for tumor using minus-strand RNA virus vector encoding immunostimulating cytokine
JPWO2005097988A1 (ja) * 2004-03-23 2008-02-28 株式会社ディナベック研究所 組織の維持および／または修復に関連する骨髄関連細胞
CN101006171A (zh) * 2004-06-24 2007-07-25 株式会社载体研究所 含有单链负链rna病毒的抗癌剂
CA2612168A1 (en) * 2005-06-14 2006-12-21 Dnavec Corporation Methods for producing antibodies
KR20080094910A (ko) * 2006-01-17 2008-10-27 디나벡크 가부시키가이샤 신규 단백질 발현계
EP2143794A1 (en) * 2007-04-27 2010-01-13 Kyushu University, National University Corporation Viral vector for gene therapy
EP2154243B1 (en) * 2007-05-17 2016-01-13 ID Pharma Co., Ltd. Method for production of dendritic cell
AU2008280436A1 (en) * 2007-07-24 2009-01-29 Stichting Katholieke Universiteit Radboud University Nijmegen Medical Centre Compositions and methods for generating an immune response in a subject
JP2010537629A (ja) * 2007-08-30 2010-12-09 アカデミシュ ジーケンハウス ビイ デ ユニヴェアズィテート ファン アムステルダム 動脈形成に関与する経路及びその使用
EP2262889B1 (en) * 2008-03-03 2017-05-03 University Of Toledo Method for the production of dendritic precursor cell line
EP2351599A4 (en) 2008-11-14 2013-05-08 Dnavec Corp METHOD FOR PRODUCING DENDRITIC CELLS
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US20220226449A1 (en) * 2019-05-31 2022-07-21 Telethon Kids Institute Immunogenic compositions

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6147185A (ja) 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst 日本脳炎ウイルスの精製方法
JPS6147186A (ja) 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst インフルエンザウイルスの精製方法
JPS6147187A (ja) 1984-08-10 1986-03-07 Chemo Sero Therapeut Res Inst 狂犬病ウイルスの精製方法
JPH084508B2 (ja) 1987-09-16 1996-01-24 国立予防衛生研究所長 組み換えワクチニアウイルス
US5124148A (en) * 1988-04-27 1992-06-23 United Cancer Research Institute Method for treating viral diseases with attenuated virus
JPH01285498A (ja) 1988-05-11 1989-11-16 Mitsubishi Heavy Ind Ltd 宇宙用パネル展開装置
TW232710B (enExample) 1991-09-13 1994-10-21 American Cyanamid Co
JPH05192160A (ja) 1992-01-20 1993-08-03 Banyu Pharmaceut Co Ltd Ｃ型肝炎ウイルスゲノムＲＮＡ、ｃＤＮＡ及びポリペプチド
JPH07502173A (ja) 1992-10-06 1995-03-09 アクゾ・ノベル・エヌ・ベー 偽性狂犬病ウイルスワクチン
US6077519A (en) * 1993-01-29 2000-06-20 University Of Pittsburgh Methods for isolation and use of T cell epitopes eluted from viable cells in vaccines for treating cancer patients
EP1314431B1 (en) * 1993-04-30 2008-07-16 Wellstat Biologics Corporation Purified compositions of Newcastle disease virus
US5744144A (en) 1993-07-30 1998-04-28 University Of Pittsburgh University Patent Committee Policy And Procedures Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
US5798100A (en) 1994-07-06 1998-08-25 Immunomedics, Inc. Multi-stage cascade boosting vaccine
US6300090B1 (en) * 1994-07-29 2001-10-09 The Rockefeller University Methods of use of viral vectors to deliver antigen to dendritic cells
KR100754091B1 (ko) 1995-10-31 2007-08-31 가부시끼가이샤 디나벡 겡뀨쇼 자율 복제 능력을 갖는 (-)쇄 ｒｎａ 바이러스 벡터
AU7335296A (en) 1995-11-01 1997-05-22 Dnavec Research Inc. Recombinant sendai virus
US6734014B1 (en) * 1996-02-08 2004-05-11 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for transforming dendritic cells and activating T cells
KR100461701B1 (ko) 1996-02-29 2005-04-06 다카라 바이오 가부시키가이샤 바이러스의정제및제거방법
EP0983345A1 (en) * 1997-05-21 2000-03-08 THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services Methods and compositions for making dendritic cells from expanded populations of monocytes and for activating t cells
DK1186667T3 (da) 1999-05-18 2007-10-22 Dnavec Research Inc Kappegendeficient virusvektor af Paramyxoviridae
US20030166252A1 (en) * 1999-05-18 2003-09-04 Kaio Kitazato Paramyxovirus-derived RNP
ATE399206T1 (de) 1999-05-18 2008-07-15 Dnavec Research Inc Ribonukleoproteinkomplex aus paramyxovirus
US20030022376A1 (en) * 1999-05-18 2003-01-30 Kaio Kitazato Paramyxovirus-derived RNP
US7226786B2 (en) * 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
EP1067179A1 (en) 1999-07-09 2001-01-10 Pierre Fabre Medicament Method to select attenuated paramyxoviridae useful for vaccines and therapeutics
US20020123479A1 (en) * 1999-12-08 2002-09-05 Song Elizabeth S. Immunostimulation mediated by gene-modified dendritic cells
US6472208B1 (en) * 1999-12-13 2002-10-29 Héma-Québec Method of producing human IFN-α using sendai virus-infected hematopoietic stem cells
US20020002143A1 (en) * 2000-03-30 2002-01-03 Munehide Kano AIDS virus vaccines using sendai virus vector
CA2322057A1 (en) * 2000-05-18 2001-11-18 Dnavec Research Inc. Paramyxovirus vectors used for transfer of foreign genes
WO2002090510A2 (en) * 2001-05-08 2002-11-14 Emory University Regulating immine responses using dendritic cells
WO2003004616A2 (en) * 2001-07-05 2003-01-16 Phylogix, Inc. Dendritic cell isolation methods
PT1441591T (pt) * 2001-09-06 2016-10-06 Northwest Biotherapeutics Inc Composições e métodos para ativaçao linfocitária de células dendríticas monocíticas e células para resposta th-1
US20050130123A1 (en) * 2001-09-18 2005-06-16 Makoto Inoue Methods of examining (-) strand rna virus vectors having lowered ability to form grains and method of constructing the same
AU2002327755A1 (en) * 2001-09-28 2003-04-14 Rush-Presbyterian-St. Luke's Medical Center Paramyxoviruses as gene transfer vectors to lung cells
US20040265272A1 (en) * 2001-09-28 2004-12-30 Aikichi Iwamoto Mammalian cell-infecting virus vector encoding epitope-bound beta2m and utilization thereof
FR2838123B1 (fr) * 2002-04-04 2005-06-10 Sanofi Synthelabo Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf
US20050191617A1 (en) * 2002-06-03 2005-09-01 Makoto Inoue Pramyxovirusl vectors encoding antibody and utilization thereof
AU2002951082A0 (en) * 2002-08-30 2002-09-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic cellular agents
AU2003275581A1 (en) * 2002-10-24 2004-05-13 Dnavec Research Inc. Method of transferring gene into t cells
AU2003296439B2 (en) * 2002-12-10 2009-05-07 Argos Therapeutics, Inc. In situ maturation of dendritic cells
AU2004286144A1 (en) * 2003-11-04 2005-05-12 Dnavec Research Inc. Method for producing gene transferred dendritic cells
AU2005205441A1 (en) * 2004-01-13 2005-07-28 Dnavec Research Inc. Gene therapy for tumor using minus-strand RNA virus vector encoding immunostimulating cytokine
CA2553976C (en) * 2004-01-22 2013-09-24 Dnavec Research Inc. Method for producing minus-strand rna viral vectors using hybrid promoter comprising cytomegalovirus enhancer and chicken .beta.-actin promoter
US20080199438A1 (en) * 2004-03-16 2008-08-21 Dnavec Research Inc. Methods For Suppressing Tumor Proliferation
JPWO2005097988A1 (ja) * 2004-03-23 2008-02-28 株式会社ディナベック研究所 組織の維持および／または修復に関連する骨髄関連細胞
CN101006171A (zh) * 2004-06-24 2007-07-25 株式会社载体研究所 含有单链负链rna病毒的抗癌剂
KR20080031167A (ko) * 2005-04-20 2008-04-08 디나벡크 가부시키가이샤 알츠하이머병 치료용의 고도로 안전한 비강투여용 유전자백신
KR20090027693A (ko) * 2006-05-31 2009-03-17 디나벡크 가부시키가이샤 알츠하이머병 치료제
EP2154243B1 (en) * 2007-05-17 2016-01-13 ID Pharma Co., Ltd. Method for production of dendritic cell

Similar Documents

Publication Publication Date Title
JP2012065652A5 (enExample)
JP2012130346A5 (enExample)
JP2019505164A5 (enExample)
JP2016528894A5 (enExample)
WO2012171026A3 (en) Methods for high yield virus production
JP2016521993A5 (enExample)
WO2013049121A3 (en) Recombinant phage and methods
JP2016501515A5 (enExample)
JP2012050449A5 (enExample)
JP2013531978A5 (enExample)
JP2015165823A5 (enExample)
JP2017524348A5 (enExample)
JP2016500260A5 (enExample)
MX382822B (es) Metodos y productos para transfeccion de celulas.
JP2016539641A5 (enExample)
JP2013516982A5 (enExample)
JP2013530680A5 (enExample)
JP2013517776A5 (enExample)
JP2014511118A5 (enExample)
WO2013033308A3 (en) Methods for tissue culture and transformation of sugarcane
MX2021009554A (es) Produccion de virus en cultivos celulares.
JP2016185168A5 (enExample)
WO2013030176A3 (en) Live attenuated influenza virus
WO2015042125A3 (en) Methods and compositions for producing hepatocyte-like cells
RU2015139592A (ru) Терминаторная последовательность sb-ubi для экспрессии генов в растениях